Literature DB >> 33978862

Understanding Opioid Actions, Pain and Analgesia: A Tribute to Dr. Gavril Pasternak.

Kelly M Standifer1, Charles E Inturrisi2, Kathleen M Foley3, Ying-Xian Pan4.   

Abstract

This special issue is a tribute to our mentor, colleague and friend, Gavril W. Pasternak, MD, PhD. Homage to the breadth and depth of his work (~ 450 publications) over a 40 career in pharmacology and medicine cannot be captured fully in one special issue, but the 22 papers collected herein represent seven of the topics near and dear to Gav's heart, and the colleagues, friends and mentees who held him near to theirs. The seven themes include: (1) sites and mechanisms of opioid actions in vivo; (2) development of novel analgesic agents; (3) opioid tolerance, withdrawal and addiction: mechanisms and treatment; (4) opioid receptor splice variants; (5) novel research tools and approaches; (6) receptor signaling and crosstalk in vitro; and (7) mentorship. This introduction to the issue summarizes contributions and includes formal and personal remembrances of Gav that illustrate his personality, warmth, and dedication to making a difference in patient care and people's lives.

Entities:  

Keywords:  Analgesia; Kratom alkaloids; Nociception/orphanin FQ; Opioid receptors; Opioid tolerance and withdrawal; Splice variants

Mesh:

Substances:

Year:  2021        PMID: 33978862     DOI: 10.1007/s10571-021-01097-0

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  29 in total

Review 1.  Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option.

Authors:  Mellar P Davis; Gavril Pasternak; Bertrand Behm
Journal:  Drugs       Date:  2018-08       Impact factor: 9.546

Review 2.  Relevance of Mu-Opioid Receptor Splice Variants and Plasticity of Their Signaling Sequelae to Opioid Analgesic Tolerance.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; Alan R Gintzler
Journal:  Cell Mol Neurobiol       Date:  2020-08-17       Impact factor: 5.046

3.  Aversive Stress Reduces Mu Opioid Receptor Expression in the Intercalated Nuclei of the Rat Amygdala.

Authors:  Shawn Gouty; Julia Tomoyasu Silveira; Thomas E Cote; Brian M Cox
Journal:  Cell Mol Neurobiol       Date:  2021-01-05       Impact factor: 5.046

Review 4.  Synthesis of the Mechanisms of Opioid Tolerance: Do We Still Say NO?

Authors:  Laura J Gledhill; Anna-Marie Babey
Journal:  Cell Mol Neurobiol       Date:  2021-03-11       Impact factor: 5.046

5.  Synthesis and Characterization of Azido Aryl Analogs of IBNtxA for Radio-Photoaffinity Labeling Opioid Receptors in Cell Lines and in Mouse Brain.

Authors:  Steven G Grinnell; Rajendra Uprety; Andras Varadi; Joan Subrath; Amanda Hunkele; Ying Xian Pan; Gavril W Pasternak; Susruta Majumdar
Journal:  Cell Mol Neurobiol       Date:  2020-05-18       Impact factor: 4.231

6.  Treatment with 5-fluoro-2-oxindole Increases the Antinociceptive Effects of Morphine and Inhibits Neuropathic Pain.

Authors:  Pablo Ferreira-Chamorro; Alejandro Redondo; Gabriela Riego; Olga Pol
Journal:  Cell Mol Neurobiol       Date:  2020-09-02       Impact factor: 5.046

7.  Purinergic Receptors Crosstalk with CCR5 to Amplify Ca2+ Signaling.

Authors:  Mizuho Horioka; Emilie Ceraudo; Emily Lorenzen; Thomas P Sakmar; Thomas Huber
Journal:  Cell Mol Neurobiol       Date:  2020-11-20       Impact factor: 5.046

8.  Regulation of Opioid Receptors by Their Endogenous Opioid Peptides.

Authors:  Achla Gupta; Srinivas Gullapalli; Hui Pan; Dinah L Ramos-Ortolaza; Michael D Hayward; Malcom J Low; John E Pintar; Lakshmi A Devi; Ivone Gomes
Journal:  Cell Mol Neurobiol       Date:  2021-01-02       Impact factor: 4.231

Review 9.  Oxycodone in the Opioid Epidemic: High 'Liking', 'Wanting', and Abuse Liability.

Authors:  Cherkaouia Kibaly; Jacob A Alderete; Steven H Liu; Hazem S Nasef; Ping-Yee Law; Christopher J Evans; Catherine M Cahill
Journal:  Cell Mol Neurobiol       Date:  2020-11-27       Impact factor: 4.231

10.  Liposomal Carrier Conjugated to APP-Derived Peptide for Brain Cancer Treatment.

Authors:  Martin Gabay; Abraham Weizman; Nidal Zeineh; Meygal Kahana; Fadi Obeid; Nahum Allon; Moshe Gavish
Journal:  Cell Mol Neurobiol       Date:  2020-10-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.